Airway Management in the Intensive Care and Regular Hospital Units During COVID-19 Pandemic
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04769154|
Recruitment Status : Not yet recruiting
First Posted : February 24, 2021
Last Update Posted : February 26, 2021
The aim of this descriptive observational study is to evaluate endotracheal intubation during COVID-19 pandemic at the AUBMC outside the OR (excluding the Emergency Department (ED)) and compare the success and complication rates with previous literature and international benchmarks. The investigators will assess the rate of successful endotracheal intubations at first attempt, the total number of attempts at endotracheal intubation, the devices used for endotracheal intubation (direct laryngoscopy, video laryngoscopy, endotracheal boogie, Fiber optic etc.…), the anesthetic drugs given before intubation, the Cormack-Lehane score (compared with previous score if present for the same patient), the MACOCHA score in addition to the complication rates including but not limited to events of hypotension (SBP < 80 mmHg), severe hypoxemia (SpO2 < 85%), respiratory or cardiac arrest.
The investigators hypothesize that endotracheal intubation outside the OR at AUBMC has higher success rates and lower complication rates as compared to the literature. The investigators believe this is due to the fact that the devices and teams available for intubation outside the OR are highly efficient and very versatile compared to other facilities.
The primary outcome of this study is to assess the success rate of endotracheal intubation at first attempt outside the operating room with direct laryngoscopy or with the use of an assisting device. The secondary outcomes will identify adverse events; mainly hypoxemia (SpO2 < 85%) and hypotension (SBP < 80 mmHg).
|Condition or disease|
|Airway Management Intensive Care Unit Covid19|
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||100 participants|
|Target Follow-Up Duration:||1 Day|
|Official Title:||Airway Management in the Intensive Care and Regular Hospital Units During COVID-19 Pandemic: A Prospective Observational Study|
|Estimated Study Start Date :||February 2021|
|Estimated Primary Completion Date :||February 2023|
|Estimated Study Completion Date :||February 2023|
- The success rate of endotracheal intubation at first attempt [ Time Frame: During endotracheal intubation ]The success rate of endotracheal intubation at first attempt outside the OR with direct laryngoscopy or the use of an assisting device
- Adverse events (Hypoxemia) [ Time Frame: During the procedure ]Hypoxemia (SpO2 < 85%)
- Adverse events (Hypotension) [ Time Frame: During the procedure ]Hypotension (SBP < 80 mmHg)